(Q54475659)

30 May 2018

title

Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes. (English)

1 reference

30 May 2018

1 reference

1 reference

11

1 reference

30 May 2018

Henryk Zulewski

8

object named as

Henryk Zulewski

1 reference

30 May 2018

Katharina Timper

1

object named as

Katharina Timper

1 reference

30 May 2018

Kaethi Dembinski

5

object named as

Kaethi Dembinski

1 reference

30 May 2018

author name string

Jean Grisouard

2

1 reference

30 May 2018

Nadine S Sauter

3

1 reference

30 May 2018

Tanja Herzog-Radimerski

4

1 reference

30 May 2018

Ralph Peterli

6

1 reference

30 May 2018

Daniel M Frey

7

1 reference

30 May 2018

Ulrich Keller

9

1 reference

30 May 2018

Beat Müller

10

1 reference

30 May 2018

publication date

23 October 2012

1 reference

30 May 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

30 May 2018

volume

304

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

E1-13

1 reference

30 May 2018

Suppression of insulin receptor binding by prolonged enteral or parenteral nutrient infusion in the rat: role of gastric inhibitory polypeptide.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Molecular basis of the synergistic production of IL-1 receptor antagonist by human neutrophils stimulated with IL-4 and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-1 activates synthesis of interleukin-6 by interfering with a KH-type splicing regulatory protein (KSRP)-dependent translational silencing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Free fatty acid regulation of glucose-dependent intrinsic oscillatory lipolysis in perifused isolated rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Mechanisms of metformin action on glucose transport and metabolism in human adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Role of calcium in lipopolysaccharide-induced calcitonin gene expression in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

GIP and bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

TIA-1 regulates the production of tumor necrosis factor alpha in macrophages, but not in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Inflammation and the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

Inverse regulation of basal lipolysis in perigonadal and mesenteric fat depots in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

p38alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00100.2012

10.1152/AJPENDO.00100.2012

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018